# Chiral Technologies

Chiral Technologies is an other based in West Chester, United States.

## Overview

- **Organization type:** other
- **Headquarters:** West Chester, United States
- **Region:** North America
- **Address:** West Chester, PA, United States
- **Assets under management:** Undisclosed
- **Website:** https://chiraltech.com

## Regulatory record

- **Reports private funds:** No

## About

CHIRAL TECHNOLOGIES, INC. supplies columns, bulk stationary phases, and separation services for enantioselective separations to pharmaceutical, biotechnology, and fine chemicals companies. The company provides products and services for chromatographic resolution. Its offerings support various aspects of enantioselective separations.

## Sectors

- Industrial Tech
- Healthcare Services

## Questions

### Why are Chiral Technologies' columns considered critical to pharmaceutical development?

Regulatory agencies including the FDA require sponsors to characterize and control the enantiomeric purity of chiral drug substances. Daicel's CHIRALPAK and CHIRALCEL polysaccharide-based columns are the most broadly applicable chiral stationary phases available and are cited in the pharmacopoeial monographs for many blockbuster single-enantiomer drugs. Once a method is validated on a specific Daicel column chemistry, switching phases requires a regulatory bridging study, creating high switching costs that effectively embed Chiral Technologies into the drug's permanent quality-control framework.

### Does Chiral Technologies operate an analytical services lab alongside its column business?

Yes, the firm maintains an applications laboratory at its West Chester headquarters that performs chiral method development and feasibility studies on a fee-for-service basis. This service acts as a demand-generation engine: chemists prove separation feasibility on Chiral Technologies' instrumentation and columns, then specify those same consumables for their internal quality-control laboratories and external CMO partners.

### Which industries outside pharmaceuticals depend on Chiral Technologies' separation media?

While small-molecule pharmaceuticals represent the overwhelming majority of demand, the firm's columns are also used in academic organic chemistry, agrochemical discovery (where single-isomer products are becoming more common), and certain flavor-and-fragrance applications where enantiomeric composition affects sensory properties. None of these verticals approaches the pharmaceutical sector in revenue concentration or regulatory stickiness.

### What is the competitive moat protecting Daicel's chiral chromatography franchise?

The moat rests on three pillars: a trade-secret-protected manufacturing process for coating polysaccharide derivatives onto silica supports, decades of published application data that make Daicel phases the default screening set in pharmaceutical method development, and regulatory-drug master filings that lock in specific column chemistries for approved products. No competing chiral stationary phase — cyclodextrin-based, Pirkle-type, or macrocyclic glycopeptide — matches the broad enantioselectivity of the polysaccharide platform across diverse small-molecule scaffolds.

## Related profiles

- [FQSR](https://altss.com/profile/fqsr)
- [1848 Capital Partners](https://altss.com/profile/1848-capital-partners)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/chiral-technologies

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology